R. Haschemeyer

Immunotherapy with anti-CD3 monoclonal antibodies and recombinant interleukin 2: stimulation of molecular programs of cytotoxic killer cells and induction of tumor regression.

Nakajima, F, Khanna, A, Xu, G, Lagman, M, Haschemeyer, R, Mouradian, J, ...

Adoptive cellular immunotherapy, infusions of interleukin 2 (IL-2) in conjunction with in vitro-activated killer cells, has brought new hope to patients with cancer. The broad application of this...

TWO CONFIGURATIONS OF TOBACCO MOSAIC VIRUS-RIBONUCLEIC ACID*

Haschemeyer, R., Singer, B., Fraenkel-Conrat, H.

Immunotherapy with anti-CD3 monoclonal antibodies and recombinant interleukin 2: stimulation of molecular programs of cytotoxic killer cells and induction of tumor regression.

Nakajima, F, Khanna, A, Xu, G, Lagman, M, Haschemeyer, R, Mouradian, J, ...

Adoptive cellular immunotherapy, infusions of interleukin 2 (IL-2) in conjunction with in vitro-activated killer cells, has brought new hope to patients with cancer. The broad application of this...

TWO CONFIGURATIONS OF TOBACCO MOSAIC VIRUS-RIBONUCLEIC ACID*

Haschemeyer, R., Singer, B., Fraenkel-Conrat, H.